Healthcare • Drug Manufacturers - General
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PFE is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
341 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: buy 63 days ago
Red flags: 0
2,842 filers reported a long position in PFE for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $12.8B | 529.7M | +6.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | $9B | 372.1M | +0.7% |
| STATE STREET CORP | $7.4B | 307.1M | +1.8% |
| GEODE CAPITAL MANAGEMENT, LLC | $3.2B | 135.3M | +1.3% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.9B | 119.2M | +2.1% |
| Fisher Asset Management, LLC | $2.6B | 109.1M | +3.9% |
| MORGAN STANLEY | $2.3B | 96.3M | +3.9% |
| NORGES BANK | $1.5B | 61.5M | — |
| NORTHERN TRUST CORP | $1.4B | 59.1M | -4.7% |
| Bank of New York Mellon Corp | $1.4B | 57.9M | +7.4% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.